دورية أكاديمية

ABCL-320 Initial Safety Run-In Results of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL

التفاصيل البيبلوغرافية
العنوان: ABCL-320 Initial Safety Run-In Results of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL
المؤلفون: Kingsley, Edwin 1, Grosicki, Sebastian 2, Kwiatek, Michal 3, Salar, Antonio 4, Snauwaert, Sylvia 5, Wang, Ying 6, Adamis, Helena 7, Wang, Luqiang 6, Depaus, Julien 8
المصدر: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S372-S372
قاعدة البيانات: ScienceDirect
الوصف
تدمد:21522650
DOI:10.1016/S2152-2650(22)01527-0